Melanoma growth, anti-tumor immune response and inflammation: a critical three-lateral interrelationship for successful immunotherapy

Number of publications: 2
Israeli Partner: M. Baniyash, Hebrew Univ.
German Partner: V. Umansky (div. of D. Schadendorf), DKFZ

Publications

Publication
Publication
Meyer, C., Sevko, A., Ramacher, M., Bazhin, A. V., Falk, C. S., Osen, W., Borrello, I., Kato, M., Schadendorf, D., Baniyash, M., Umansky, V.

Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model 108 (41), Proc Natl Acad Sci U S A, 17111-6, 2011

Sevko, A., Sade-Feldman, M., Kanterman, J., Michels, T., Falk, C. S., Umansky, L., Ramacher, M., Kato, M., Schadendorf, D., Baniyash, M., Umansky, V.

Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma 133 (6), J Invest Dermatol, 1610-9, 2013

to top